290 related articles for article (PubMed ID: 27603935)
1. Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States.
Friedman DJ; Parzynski CS; Varosy PD; Prutkin JM; Patton KK; Mithani A; Russo AM; Curtis JP; Al-Khatib SM
JAMA Cardiol; 2016 Nov; 1(8):900-911. PubMed ID: 27603935
[TBL] [Abstract][Full Text] [Related]
2. Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis.
Pun PH; Parzynski CS; Friedman DJ; Sanders G; Curtis JP; Al-Khatib SM
Clin J Am Soc Nephrol; 2020 Nov; 15(11):1622-1630. PubMed ID: 32967922
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement.
Mithani AA; Kath H; Hunter K; Andriulli J; Ortman M; Field J; Russo AM
Europace; 2018 Feb; 20(2):308-314. PubMed ID: 28383717
[TBL] [Abstract][Full Text] [Related]
4. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
[TBL] [Abstract][Full Text] [Related]
5. Trends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018.
Borne RT; Varosy P; Lan Z; Masoudi FA; Curtis JP; Matlock DD; Peterson PN
JAMA Netw Open; 2022 Mar; 5(3):e223429. PubMed ID: 35315917
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
[TBL] [Abstract][Full Text] [Related]
7. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
[TBL] [Abstract][Full Text] [Related]
8. Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry.
Friedman DJ; Parzynski CS; Heist EK; Russo AM; Akar JG; Freeman JV; Curtis JP; Al-Khatib SM
Circulation; 2018 Jun; 137(23):2463-2477. PubMed ID: 29463509
[TBL] [Abstract][Full Text] [Related]
9. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
Dewland TA; Pellegrini CN; Wang Y; Marcus GM; Keung E; Varosy PD
J Am Coll Cardiol; 2011 Aug; 58(10):1007-13. PubMed ID: 21867834
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients.
Friedman DJ; Qin L; Parzynski C; Heist EK; Russo AM; Ranasinghe I; Zeitler EP; Minges KE; Akar JG; Freeman JV; Curtis JP; Al-Khatib SM
J Am Coll Cardiol; 2022 Mar; 79(11):1050-1059. PubMed ID: 35300816
[TBL] [Abstract][Full Text] [Related]
11. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.
Charytan DM; Patrick AR; Liu J; Setoguchi S; Herzog CA; Brookhart MA; Winkelmayer WC
Am J Kidney Dis; 2011 Sep; 58(3):409-17. PubMed ID: 21664735
[TBL] [Abstract][Full Text] [Related]
12. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.
Chen CY; Stevenson LW; Stewart GC; Bhatt DL; Desai M; Seeger JD; Williams L; Jalbert JJ; Setoguchi S
BMJ; 2015 Jul; 351():h3529. PubMed ID: 26174233
[TBL] [Abstract][Full Text] [Related]
13. Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation.
Viani S; Migliore F; Tola G; Pisanò ECL; Russo AD; Luzzi G; Sartori P; Piro A; Rordorf R; Forleo GB; Rago A; Segreti L; Bertaglia E; Biffi M; Lovecchio M; Valsecchi S; Diemberger I; Bongiorni MG
Heart Rhythm; 2019 Apr; 16(4):564-571. PubMed ID: 30366163
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Temporal Trends and Variation in the Use of Defibrillation Testing in Contemporary Practice.
Borne RT; Randolph T; Wang Y; Curtis JP; Peterson PN; Masoudi FA; Sandhu A; Zipse MM; Thomas K; Kutyifa V; Desai NR; Cha YM; Hsu JC; Russo AM
JAMA Netw Open; 2019 Oct; 2(10):e1913553. PubMed ID: 31626314
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
[TBL] [Abstract][Full Text] [Related]
16. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
[TBL] [Abstract][Full Text] [Related]
17. Single- Versus Dual-Chamber Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States.
Margolis G; Hamuda N; Kobo O; Elbaz Greener G; Amir O; Homoud M; Madias C; Heist EK; Ruskin JN; Kazatsker M; Roguin A; Leshem E; Rozen G
J Am Heart Assoc; 2023 Aug; 12(15):e029126. PubMed ID: 37522389
[TBL] [Abstract][Full Text] [Related]
18. Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR
Gleva MJ; Wang Y; Curtis JP; Berul CI; Huddleston CB; Poole JE
Am J Cardiol; 2017 Nov; 120(10):1891-1898. PubMed ID: 28917495
[TBL] [Abstract][Full Text] [Related]
19. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry.
Arnson Y; Suleiman M; Glikson M; Sela R; Geist M; Amit G; Schliamser JE; Goldenberg I; Ben-Zvi S; Orvin K; Rosenheck S; Adam Freedberg N; Strasberg B; Haim M
Heart Rhythm; 2014 May; 11(5):814-21. PubMed ID: 24486799
[TBL] [Abstract][Full Text] [Related]
20. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
